Targets and achievements
We have set targets in accordance with our key sustainability themes and we monitor their achievement on a regular basis. We have developed a quality index to promote the reporting and transparency of quality by measuring clinical and experienced quality, access to care as well as preventive care. The quality index consists of seven different impact indicators and we use it to measure clinical, experienced and process results based on international best practices. Our climate goal is to achieve zero emissions in our own operations in 2030.
Good health and well-being
| Area | Target | Indicator | Target | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Quality index: High clinical and experienced quality, access to care and preventive care |
Use of the WHO Surgical Safety Checklist in over 99% of surgical operations | Use of the WHO Surgical Safety Checklist in surgical operations | >99% | 98.9% | 99.8% | 97.8% |
| Prescriptions for drugs affecting the central nervous system in relation to visits to a physician below 3.5% | Prescriptions for drugs affecting the central nervous system in relation to visits to a physician | <3.5% | 4.0% | 4.3% | 4.6% | |
| Duration of sickness absence issued on the day of the operation (median), repair of the rotator cuff and the anterior cruciate ligament <28 days |
Duration of sickness absence issued on the day of the operation (median), repair of the rotator cuff and the anterior cruciate ligament |
<28 | 30 | 32 | 36 | |
| Percentage of preventive work of occupational health appointments over 60% |
Percentage of preventive work of occupational health appointments | >60% | 69.6% | 70.2% | 67.8% | |
| Days until next available appointment, clinics (T3) below 1.00 | T3, i.e. the third available appointment | <1.00 | 1.93 | 1.61 | 1.17 | |
| Appointment NPS over 74 | Appointment NPS | >74 | 82.7 | 83.0 | 82.8 | |
| eNPS at least 14 in 2021 | eNPS | 14 | 29 | 32 | 18 | |
| Quality index total | Quality index, % | 100 | 92.2 | 94.6 | 94.2 | |
| Access to care, public services | Days until next available appointment (T3) public services <7 for a physician, <1 for a nurse | T3, i.e. the third available appointment with a physician | <7 | 12.0 | 6.5 | 5.6 |
| T3, i.e. the third available appointment with a nurse | <1 | 2 | 1 | 1 | ||
| Patient safety | Reimbursed patient claims / appointments with a physician | 0.0016% | 0.0019% | 0.0021% | ||
| Near misses/hazardous incidents | 56.9% | 50.0% | 57.0% |
The figures include Terveystalo's operations in Finland.
Ethical business
| Area | Target | Indicator | Target | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Employees who have completed orientation training on the Code of Conduct and correct action |
100% of our employees have completed the training |
Percentage of employees who have completed the training relative to all employees 1) |
100% | 69.2% | 66.0% | 52.3% |
| Suppliers who have approved the Supplier Code of Conduct |
100% of our suppliers have approved the Supplier Code of Conduct |
Percentage of suppliers who have approved the Supplier Code of Conduct relative to all suppliers (of suppliers representing 80% of total purchases) |
100% | 80% | 80% | 80% |
1) The training periods have been of different lengths. The figures for 2022 also include performances during the second half of 2021, which is why the figures are not fully comparable.
The figures include Terveystalo's operations in Finland.
Resbonsible work
| Area | Target | Indicator | Target | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
|
Occupational safety |
Accident rate below the sector average |
Accident rate |
< 34 (sector average) |
15 | 20 | 25 |
|
Personnel’s well-being |
Reducing sickness absences |
Sickness absences |
- |
5.2% | 4.4% | 3.8% |
|
Employer recommended by the personnel |
Improving the employee promoter score |
eNPS |
31 by 2025 |
29 |
32 |
18 |
The figures include Terveystalo's operations in Finland.
Sustainable economic growth
| Area | Target | Indicator | Target | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
|
Tax footprint |
We openly disclose our tax footprint annually. |
Tax footprint, EUR million |
- |
235.7 | 191.0 | 152.3 |
|
Revenue growth |
Minimum annual growth 5% |
Revenue growth, % |
5% |
9.0% | 17.1% | -4.3% |
|
The people we employ |
We create jobs. |
Employee benefit expenses, EUR million |
- |
455.0 | 378.2 | 310.2 |
Sustainable consumption and climate action
| Area | Target | Indicator | Target | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Reducing the carbon footprint
|
Zero emissions from own operations in 2030. 1) Between 2023 and 2030, we will compensate for any remaining greenhouse gas emissions by investing in certified carbon dioxide emission compensation projects. | Reduction of direct (scope 1) and indirect (scope 2) greenhouse gas emissions compared to 2018 (6,316.8 tCO2) | -100% by 2030 | -61% | -89% | -66% |
|
|
We will reduce direct and indirect CO2 emissions (Scope 1 and Scope 2) by 80% by 2025 (using 2018 as the baseline) | Direct (scope 1) and indirect (scope 2) greenhouse gas emissions, tCO2 | -80% by 2025 | 2476.3 | 664.0 | 2165.4 |
| Energy consumption | We will purchase 100% green electricity by 2025 2) | Share of green electricity of all purchased electricity, % | 100% by 2025 | 50% | 89% | 62% |
| Waste recovery 4)
|
We will minimize waste in all of our operations and forward all waste to be recovered
|
The recovery rate of waste generated at Terveystalo units, % 3) | 100% by 2025 | 100% | 100% | 99% |
| The recycling rate of waste generated at Terveystalo units, % 3) | 100% by 2025 | 67% | 64% |
61% |
||
|
Mixed waste intensity (mixed waste [metric tons] relative to total revenue [100 million]) |
Annual reduction |
5.8 |
6.4 |
6.0 |
1) Between 2023 and 2030, we will compensate for any remaining greenhouse gas emissions by investing in certified carbon dioxide emission compensation projects. Our aim is to eventually discontinue compensation measures and to achieve zero emissions in our own operations by 2030. In 2022 emissions were not compensated due to cost savings. The calculation of Scope 2 emissions is market-based. The exceptional electricity market disturbances forced Terveystalo to change its electricity supplier in the middle of the year, and because of the high market price of electricity, no green electricity was purchased for the rest of the year. The calculation of the market-based figure is based on the emission factor of the electricity purchased by Terveystalo in Finland, while the location-based figure is calculated according to a factor based on the source distribution of local energy production. The amount of green electricity from the electricity purchased in Sweden has been calculated according to the average share of green electricity in the Swedish market, since supplier-specific information is not available. The energy consumption and carbon footprint figures for 2022 also include operations in Sweden. Comparison years only include Finland.
2) In the units where we purchase electricity ourselves.
3) Excludes waste fractions that cannot be recycled or recovered under any circumstances, such as hazardous waste.
4) Includes Terveystalo's operations in Finland.